Automated brain tumor recognition using equilibrium optimizer with deep learning approach on MRI images
Mahmoud Ragab1, Iyad Katib2, Sanaa A Sharaf2
1Information Technology Department, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. mragab@kau.edu.sa.
Scientific Reports
|November 28, 2024
Summary
This study introduces a novel AI approach for brain tumor recognition in MRI scans. The BTR-EODLA technique achieves 98.78% accuracy, improving diagnostic capabilities.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Deep Learning
Background:
- Brain tumors (BT) pose significant health risks due to their location.
- Artificial intelligence (AI), including deep learning (DL) and machine learning (ML), offers advanced tools for disease diagnosis and treatment.
- AI analyzes brain Magnetic Resonance Imaging (MRI) to identify and categorize tumors, aiding medical professionals in diagnosis and treatment planning.
Purpose of the Study:
- To develop and validate a novel AI technique for accurate brain tumor recognition in MRI images.
- To enhance the early detection and classification of brain tumors using deep learning and optimization algorithms.
Main Methods:
- The Brain Tumor Recognition using an Equilibrium Optimizer with a Deep Learning Approach (BTR-EODLA) technique was employed.
- Median filtering (MF) was used for noise reduction in MRI images.
- Squeeze-excitation ResNet (SE-ResNet50) extracted features, optimized by the Equilibrium Optimizer (EO), and a stacked autoencoder (SAE) performed tumor detection.
Main Results:
- The BTR-EODLA technique demonstrated high performance in brain tumor recognition.
- Experimental validation showed a superior accuracy of 98.78% compared to existing models.
- The method effectively identifies the presence of brain tumors in MRI scans.
Conclusions:
- The BTR-EODLA technique offers a highly accurate and effective solution for brain tumor detection using AI and deep learning on MRI data.
- This AI-driven approach has the potential to significantly improve diagnostic accuracy and patient management in neuro-oncology.


